Cancer treatment and monitoring methods using OX40 agonists

• 收藏
• 分享

专利权人:

Ed Walker;Josh Walker;Brendan Curti;Andy Weinberg;Magdalena Kovacsovics-Bankowski

发明人:

Brendan Curti,Magdalena Kovacsovics-Bankowski,Ed Walker,Josh Walker,Andy Weinberg

申请号：

US14376998

公开号：

US09828432B2

申请日:

2012.02.06

申请国别(地区):

US

年份:

2017

代理人:

摘要：

OX40 is a potent immune stimulating target. Provided herein are methods for the treatment of cancer patients using (3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40-induced T cell proliferation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/